Down-regulation of BiP/GRP78 sensitizes resistant prostate cancer cells to gene-therapeutic overexpression of REIC/Dkk-3

Ryuta Tanimoto, Masakiyo Sakaguchi, Fernando Abarzua, Ken Kataoka, Kaoru Kurose, Hitoshi Murata, Yasutomo Nasu, Hiromi Kumon, Nam Ho Huh

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

We have recently shown that an adenovirus carrying REIC/Dkk-3 (Ad-REIC) exhibits a potent tumor-specific cell-killing function for various human cancers. It has also become evident that some human cancers are resistant to Ad-REIC-induced apoptosis. The aim of the present study was to determine the molecular mechanisms of resistance to Ad-REIC. First, we isolated resistant clones from a human prostate cancer cell line, PC3, after repeated exposure to Ad-REIC. Infection efficiency of the adenovirus vector and expression level of REIC/Dkk-3 in the resistant clones were similar to those in the parental PC3 cells. By screening for alteration in levels and functional status of proteins involved in Ad-REIC-induced apoptosis, we found that BiP/GRP78, an ER-residing chaperone protein, was expressed at higher levels consistently among resistant cells. Expression levels of BiP and rates of apoptosis induced by Ad-REIC were inversely correlated. Down-regulation of BiP with siRNA sensitized the resistant cells to Ad-REIC in vivo as well as in culture. These results indicate that BiP is a major determinant of resistance to Ad-REIC-induced apoptosis. Thus BiP is useful for diagnosis of inherent and acquired resistance of cancers and also as a target molecule to overcome resistance to the gene therapeutic Ad-REIC.

Original languageEnglish
Pages (from-to)1562-1569
Number of pages8
JournalInternational Journal of Cancer
Volume126
Issue number7
DOIs
Publication statusPublished - Apr 1 2010

Fingerprint

Adenoviridae
Prostatic Neoplasms
Down-Regulation
Genes
Apoptosis
Therapeutics
Neoplasms
Clone Cells
Adenoviridae Infections
Small Interfering RNA
Proteins
Cell Line

Keywords

  • Apoptosis
  • Dkk
  • ER stress
  • GRP78
  • REIC

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

Down-regulation of BiP/GRP78 sensitizes resistant prostate cancer cells to gene-therapeutic overexpression of REIC/Dkk-3. / Tanimoto, Ryuta; Sakaguchi, Masakiyo; Abarzua, Fernando; Kataoka, Ken; Kurose, Kaoru; Murata, Hitoshi; Nasu, Yasutomo; Kumon, Hiromi; Huh, Nam Ho.

In: International Journal of Cancer, Vol. 126, No. 7, 01.04.2010, p. 1562-1569.

Research output: Contribution to journalArticle

Tanimoto, Ryuta ; Sakaguchi, Masakiyo ; Abarzua, Fernando ; Kataoka, Ken ; Kurose, Kaoru ; Murata, Hitoshi ; Nasu, Yasutomo ; Kumon, Hiromi ; Huh, Nam Ho. / Down-regulation of BiP/GRP78 sensitizes resistant prostate cancer cells to gene-therapeutic overexpression of REIC/Dkk-3. In: International Journal of Cancer. 2010 ; Vol. 126, No. 7. pp. 1562-1569.
@article{1fa7724897b741ec9257afdd265e1ff7,
title = "Down-regulation of BiP/GRP78 sensitizes resistant prostate cancer cells to gene-therapeutic overexpression of REIC/Dkk-3",
abstract = "We have recently shown that an adenovirus carrying REIC/Dkk-3 (Ad-REIC) exhibits a potent tumor-specific cell-killing function for various human cancers. It has also become evident that some human cancers are resistant to Ad-REIC-induced apoptosis. The aim of the present study was to determine the molecular mechanisms of resistance to Ad-REIC. First, we isolated resistant clones from a human prostate cancer cell line, PC3, after repeated exposure to Ad-REIC. Infection efficiency of the adenovirus vector and expression level of REIC/Dkk-3 in the resistant clones were similar to those in the parental PC3 cells. By screening for alteration in levels and functional status of proteins involved in Ad-REIC-induced apoptosis, we found that BiP/GRP78, an ER-residing chaperone protein, was expressed at higher levels consistently among resistant cells. Expression levels of BiP and rates of apoptosis induced by Ad-REIC were inversely correlated. Down-regulation of BiP with siRNA sensitized the resistant cells to Ad-REIC in vivo as well as in culture. These results indicate that BiP is a major determinant of resistance to Ad-REIC-induced apoptosis. Thus BiP is useful for diagnosis of inherent and acquired resistance of cancers and also as a target molecule to overcome resistance to the gene therapeutic Ad-REIC.",
keywords = "Apoptosis, Dkk, ER stress, GRP78, REIC",
author = "Ryuta Tanimoto and Masakiyo Sakaguchi and Fernando Abarzua and Ken Kataoka and Kaoru Kurose and Hitoshi Murata and Yasutomo Nasu and Hiromi Kumon and Huh, {Nam Ho}",
year = "2010",
month = "4",
day = "1",
doi = "10.1002/ijc.24764",
language = "English",
volume = "126",
pages = "1562--1569",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "7",

}

TY - JOUR

T1 - Down-regulation of BiP/GRP78 sensitizes resistant prostate cancer cells to gene-therapeutic overexpression of REIC/Dkk-3

AU - Tanimoto, Ryuta

AU - Sakaguchi, Masakiyo

AU - Abarzua, Fernando

AU - Kataoka, Ken

AU - Kurose, Kaoru

AU - Murata, Hitoshi

AU - Nasu, Yasutomo

AU - Kumon, Hiromi

AU - Huh, Nam Ho

PY - 2010/4/1

Y1 - 2010/4/1

N2 - We have recently shown that an adenovirus carrying REIC/Dkk-3 (Ad-REIC) exhibits a potent tumor-specific cell-killing function for various human cancers. It has also become evident that some human cancers are resistant to Ad-REIC-induced apoptosis. The aim of the present study was to determine the molecular mechanisms of resistance to Ad-REIC. First, we isolated resistant clones from a human prostate cancer cell line, PC3, after repeated exposure to Ad-REIC. Infection efficiency of the adenovirus vector and expression level of REIC/Dkk-3 in the resistant clones were similar to those in the parental PC3 cells. By screening for alteration in levels and functional status of proteins involved in Ad-REIC-induced apoptosis, we found that BiP/GRP78, an ER-residing chaperone protein, was expressed at higher levels consistently among resistant cells. Expression levels of BiP and rates of apoptosis induced by Ad-REIC were inversely correlated. Down-regulation of BiP with siRNA sensitized the resistant cells to Ad-REIC in vivo as well as in culture. These results indicate that BiP is a major determinant of resistance to Ad-REIC-induced apoptosis. Thus BiP is useful for diagnosis of inherent and acquired resistance of cancers and also as a target molecule to overcome resistance to the gene therapeutic Ad-REIC.

AB - We have recently shown that an adenovirus carrying REIC/Dkk-3 (Ad-REIC) exhibits a potent tumor-specific cell-killing function for various human cancers. It has also become evident that some human cancers are resistant to Ad-REIC-induced apoptosis. The aim of the present study was to determine the molecular mechanisms of resistance to Ad-REIC. First, we isolated resistant clones from a human prostate cancer cell line, PC3, after repeated exposure to Ad-REIC. Infection efficiency of the adenovirus vector and expression level of REIC/Dkk-3 in the resistant clones were similar to those in the parental PC3 cells. By screening for alteration in levels and functional status of proteins involved in Ad-REIC-induced apoptosis, we found that BiP/GRP78, an ER-residing chaperone protein, was expressed at higher levels consistently among resistant cells. Expression levels of BiP and rates of apoptosis induced by Ad-REIC were inversely correlated. Down-regulation of BiP with siRNA sensitized the resistant cells to Ad-REIC in vivo as well as in culture. These results indicate that BiP is a major determinant of resistance to Ad-REIC-induced apoptosis. Thus BiP is useful for diagnosis of inherent and acquired resistance of cancers and also as a target molecule to overcome resistance to the gene therapeutic Ad-REIC.

KW - Apoptosis

KW - Dkk

KW - ER stress

KW - GRP78

KW - REIC

UR - http://www.scopus.com/inward/record.url?scp=77449094442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77449094442&partnerID=8YFLogxK

U2 - 10.1002/ijc.24764

DO - 10.1002/ijc.24764

M3 - Article

C2 - 19626590

AN - SCOPUS:77449094442

VL - 126

SP - 1562

EP - 1569

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 7

ER -